|
|
| Line 1: |
Line 1: |
| <center>'''IHE Anatomic Pathology Domain F2F Meeting'''</center>
| |
|
| |
|
| <center>'''August 5-6, 2013 Paris'''</center>
| |
|
| |
|
| |
|
| |
| '''Attending:'''
| |
|
| |
| {| class="prettytable"
| |
| |-
| |
| |
| |
| '''Participants IHE AP'''
| |
|
| |
| |
| |
| <center>'''August 5'''</center>
| |
|
| |
| |
| |
| <center>'''August 6'''</center>
| |
|
| |
| |
| |
| <center>'''Organization'''</center>
| |
|
| |
| |-
| |
| |
| |
| David Booker
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| College of American Pathologists/LabMedicine PC
| |
|
| |
| |-
| |
| |
| |
| Christel Daniel
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| CCS Domaine Patient - AP-HP - INSERM
| |
|
| |
| |-
| |
| |
| |
| Raj Dash
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| College of American Pathologists/Duke University
| |
|
| |
| |-
| |
| |
| |
| Gunter Haroske
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| Institute für Pathologie
| |
|
| |
| KH Dresden-Friedrichstadt
| |
|
| |
| HU Berlin Charite
| |
|
| |
| FH Brandenburg
| |
|
| |
| |-
| |
| |
| |
| Mary Kennedy
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| College of American Pathologists
| |
|
| |
| |-
| |
| |
| |
| Jacques Klossa
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| Telepathology2014
| |
|
| |
| |-
| |
| |
| |
| François Macary
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| ASIP Santé
| |
|
| |
| |-
| |
| |
| |
| Thomas Schrader
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| Institute für Pathologie
| |
|
| |
| KH Dresden-Friedrichstadt
| |
|
| |
| HU Berlin Charite
| |
|
| |
| FH Brandenburg
| |
|
| |
| |-
| |
| |
| |
| Riccardo Triunfo
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| CRS4
| |
|
| |
| |-
| |
| |
| |
| Gianluigi Zanetti
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| <center>X</center>
| |
|
| |
| |
| |
| CRS4
| |
|
| |
| |}
| |
| '''NOTE: Presentations referenced can be found on the IHE AP Domain wiki site: '''
| |
|
| |
| '''[http://wiki.ihe.net/index.php?title=Anatomic_Pathology http://wiki.ihe.net/index.php?title=Anatomic_Pathology''']
| |
|
| |
|
| |
|
| |
| '''Agenda Items'''
| |
|
| |
| * IHE Lab Overview
| |
| * APSR release 2013
| |
| * Change proposal modification to incorporate APSR
| |
| * Incorporation of Molecular Pathology/Genomics Requirements
| |
| * Strategy Session Initiation
| |
| * Telepathology
| |
| * Organization of Future Meetings
| |
|
| |
|
| |
|
| |
| '''Action Items'''
| |
|
| |
| {| class="prettytable"
| |
| |-
| |
| |
| |
| '''<nowiki>#</nowiki>'''
| |
|
| |
| |
| |
| '''Item'''
| |
|
| |
| |
| |
| '''Responsible'''
| |
|
| |
| |
| |
| '''Status'''
| |
|
| |
| |-
| |
| |
| |
| 1
| |
|
| |
| |
| |
| Contact Chris Carr to determine if IHE has an IHTSDO namespace we could use
| |
|
| |
| |
| |
| Mary
| |
|
| |
| |
| |
| Open
| |
|
| |
| |-
| |
| |
| |
| 2
| |
|
| |
| |
| |
| Determine if IHE needs permission from AJCC to use TNM terms in APSR
| |
|
| |
| |
| |
| Mary
| |
|
| |
| |
| |
| Open
| |
|
| |
| |-
| |
| |
| |
| 3
| |
|
| |
| |
| |
| Create change proposal for APSR
| |
|
| |
| |
| |
| Thomas / Gunter
| |
|
| |
| |
| |
| Completed (see document)
| |
|
| |
| |-
| |
| |
| |
| 4
| |
|
| |
| |
| |
| Request LOINC codes for Observation codes for APSR
| |
|
| |
| |
| |
| TBD
| |
|
| |
| |
| |
| Open
| |
|
| |
| |-
| |
| |
| |
| 5
| |
|
| |
| |
| |
| Create a model for workflow use case
| |
|
| |
| |
| |
| Gianluigi/Riccardo
| |
|
| |
| |
| |
| November
| |
|
| |
| |-
| |
| |
| |
| 6
| |
|
| |
| |
| |
| Create a use case for image reporting to be merged into CRS4 profile proposal
| |
|
| |
| |
| |
| Jacques
| |
|
| |
| |
| |
| November
| |
|
| |
| |-
| |
| |
| |
| 7
| |
|
| |
| |
| |
| Send out call for new proposals
| |
|
| |
| |
| |
| Co-chairs/Mary
| |
|
| |
| |
| |
| November
| |
|
| |
| |-
| |
| |
| |
| 8
| |
|
| |
| |
| |
| Update IHE Domain page
| |
|
| |
| (change Trial Implementation RePub Request to 2013-10-31,etc.)
| |
|
| |
| |
| |
| Mary
| |
|
| |
| |
| |
| November
| |
|
| |
| |-
| |
| |
| |
| 9
| |
|
| |
| |
| |
| Creation of examples of cancer/non-cancer (eg, breast/prostate; fibroadenoma) to be developed by France/Germany/US
| |
|
| |
| |
| |
| Christel/Thomas/Raj
| |
|
| |
| |
| |
| November
| |
|
| |
| |-
| |
| |
| |
| 10
| |
|
| |
| |
| |
| Write summary of discussion and contact Epic development
| |
|
| |
| |
| |
| Raj
| |
|
| |
| |
| |
| November
| |
|
| |
| |-
| |
| |
| |
| 11
| |
|
| |
| |
| |
| Develop mapping of values based on text using Excel template (Christel will share prototype Excel File)
| |
|
| |
| |
| |
| Christel
| |
|
| |
| |
| |
| Completed
| |
|
| |
| |}
| |
|
| |
|
| |
| '''Minutes'''
| |
|
| |
| # Welcome/Introductions
| |
| ## No domain sponsor announcements; however, the IHE AP meeting roster was updated.
| |
| ## Agenda reviewed and approved
| |
| ## Objectives of meeting:
| |
| ### Enumerate current projects and statuses
| |
| ### Lower barrier to incorporation of concepts into SNOMED CT
| |
| ### Identify ways to incorporate multinational vendor engagement
| |
| # Overview of IHE Lab work (Francois)
| |
| ## ILW has a change proposal from Harry Solomon that could be used for AP
| |
| ### Telepathology consultation
| |
| ## Lab Code Set distribution profile (IPI domain?) (Francois to share?)
| |
| ### LOINC recommended (Japan incorporating LOINC)
| |
| ### JLAC-10 Japanese required coding system
| |
| ## Implementation of IHE Lab profiles in France
| |
| ### XD-LAB accepted as national framework for France
| |
| #### Lab reports need to be conformant to XD-Lab to go into EHR
| |
| #### LTW (APHP); LCSD and LTW deployed in France
| |
| #### LOINC has been selected for France and has been partially translated in French (20,000 codes to date)
| |
| # CRS4 presentation: Can/How do we put data intensive biology in the picture? (see presentation)(Riccardo/Gianluigi)
| |
| ## CRS4 is an interdisciplinary, not for profit research center focused on computational sciences
| |
| ## Focus on clinical domain interconnection and traceability; semantic and computable management of biomedical data; telemedicine and distributed medicine
| |
| ## Main IHE experience in the IHE Lab and ITI domains
| |
| ### Technical framework supplement for lab specimen barcode labeling
| |
| ### One CRS4 monitor at Connectathon 2013
| |
| ## Currently dealing with production, managing and analysis of data intensive biology outputs (NGS, proteomics, etc) and moving toward confluence with digital pathology
| |
| ### Support to large scale population studies
| |
| ### Genetic therapy quality control
| |
| ## Building a biobank system
| |
| ### To provide consistent computable platform
| |
| ### To support scalable error propagation/graph of dependency data model
| |
| ## Industrial consulting
| |
| ### Pre-analytic automation and clinical lab automation systems
| |
| ## Support to regional healthcare systems
| |
| ### HL7/IHE integration
| |
| ### Clinical processes modeling
| |
| ### Real time telemedicine systems
| |
| ## Reasons for approaching IHE AP domain WG:
| |
| ### Research interests and their intersection
| |
| ### Is there a basis for a new IHE profile for this?
| |
| ### New profile could fuse data intensive molecular biology with digital pathology using extensive automation of pathology lab (tissue transport; processing; imaging; NGS and mass spectrometry; archive and storage)
| |
| ### A new profile could also include ordering ancillary techniques and molecular biology (Review IHE Lab automation profile/LAW)
| |
| ## New profile needs to address the following
| |
| ### Ways to do referencing
| |
| ### Expressions to show that result is tied to a specific area of a specific specimen
| |
| ### How to deal with links
| |
| ### Reference implementation
| |
| ### Need for a model for workflow (Gianluigi/Riccardo to write use case)
| |
| ### Need for a use case to show integration with AP
| |
| ### Will need to review previous DICOM work on workflow
| |
| ### Develop a use case for image reporting that can be merged into the profile (Jacques)
| |
| # APSR overview of current work (see presentation)(Francois/Christel)
| |
| ## APSR in a CDA format
| |
| ### Six 1st level sections
| |
| ### Only one mandatory and mandating structured data elements
| |
| ## Handling “none” in an observation of the <entry>
| |
| ### “None” and “None known” represent effective values which are part of the value sets attached to the observation
| |
| ## Handling missing information in an observation of the <entry>
| |
| ### These situations are handled with the nullFlavor attribute
| |
| ## Handling unexpected information in an observation of the <entry>
| |
| ### “Other, specify” – The actual value does not belong to the assigned value set and the author of the report provides this ''foreign value''
| |
| ### The value set is open to extensions
| |
| ### No code is available in any terminology for the value observed
| |
| ## New APSR templates
| |
| ### Ten new templates representing cancers
| |
| # APSR change proposal discussion (see presentation)(Thomas/Gunter)
| |
| ## Background for German/Austrian proposal
| |
| ### HL7 background reviewed
| |
| ### HL7 Germany has solutions for reporting to cancer registries using generic TNM and ICD-O
| |
| ### Uses Detailed Clinical Models (DCM)
| |
| ### Recommend using a generic model of meaning vs perpetuated specific observations (DCM)
| |
| ### Organ specific templates well suited for data entry and communication but are not suited for system maintenance
| |
| ### Can be supported by CDA
| |
| ### PathLex is logical consequence of organ specific template approach but causes unnecessary multiplication of terms
| |
| ## Proposed changes to APSR by German/Austrian workgroup:
| |
| ### Create HL7 generic model value for concepts (eg, TNM; tumor descriptions; assessment scales;)
| |
| ### Open APSR 05 and replace by TNM/ICD-O German, with consecutive changes in PathLex
| |
| ### Cancel 4.1.2.2 organ-specific APSR document content modules with consecutive changes in PathLex
| |
| ### Create generic document modules and templates only and organ-specific templates are now part of the appendix to be used for example, as blueprints for data entry forms (checklist functionality)
| |
| ### Re-launch of an ontology based PathLex (for AP observations)
| |
| ### Need to differentiate between terminology models, specimen and problem organizers
| |
| ### Advantages to this approach are few, easy to implement generic templates that can be reused in other profiles (eg, QRPH-Ca; XDS-MS)
| |
| ### Separate validation using schematron can be used
| |
| ### Would need approximately 15 required elements in total
| |
| ## Discussion of new proposal/next steps
| |
| ### Acceptance of concept of a more generic model
| |
| ### Current APSR files will be used as examples
| |
| ### Thomas/Gunter to submit a change proposal (see document)
| |
| ### Determine if IHE needs agreement with AJCC to use TNM in a profile
| |
| ### Decision is to accept many proposed changes
| |
| ### A generic model for APSR will be created and the appendix will contain examples of specific malignant and benign conditions
| |
| ### The general structure of APSR will not change and follows the CDA hierarchical tree of section, entries, organizers
| |
| ### Need to correlate radiology/pathology diagnosis (Birads)(Tumor board templates within IHE France may serve as a model)
| |
| ### Examples of cancer/non-cancer (eg breast/prostate ca; fibroadenoma) will be developed by France/Germany/US (Chirstel/Thomas/Raj)
| |
| ### Share mapping of values based on text using Excel template (Christel will share prototype Excel file)(see spreadsheet)
| |
| ### Write summary of discussion and contact Epic development (Raj)
| |
|
| |
| Note: A change proposal was submitted by Thomas/Gunter post-meeting. Christel reviewed and edited the CP. (See document). Further discussion of the CP and final determination will occur on the next IHE AP conference call.
| |
|
| |
| # APSR/CDISC (Christel)
| |
| ## Possible collaboration with CDISC
| |
| ## Clinical Data Warehouse and i2B2
| |
| ## Unicare – clinical data warehouse
| |
| ## Uses IHE QRPH Exchange profile
| |
| ## Should we collaborate with CDISC SHARE OPEN project?
| |
| ## Christel will forward information of next IHE AP conference call
| |
| # IHTSDO/SNOMED CT and AJCC
| |
| ## Discussion regarding APSR example concepts (eg, cancer staging)
| |
| ## PathLex developed as stop gap for concepts without SCT codes
| |
| ## Should we build an SCT extension for concepts not covered in SCT?
| |
| ### Determine if IHE has an IHTSDO namespace (Mary)
| |
| ### Draft proposal for assignment of extension namespace to IHE vs IHE AP or draft joint proposal with IPaLM SIG and submit from within the IHTSDO governance
| |
| ### Alternatively, use LOINC codes immediately for observation names until such time as a SNOMED CT option is available
| |
| ## AJCC / UICC discussion
| |
| ### Determine if an IP agreement is needed between staging organizations and IHE
| |
| ### Use LOINC codes until such time as IP agreement established
| |
| ## Further discussion is needed on next steps
| |
| ## Discussion of Procedure/Specimen Type
| |
| ### Review Marcial’s work (possibly have him present on next conference call)
| |
| # 12th European Congress on Digital Pathology
| |
| ## Formerly “12th European Congress on Telepathology and 6th International Congress on Virtual Microscopy”
| |
| ## To be held in Paris 18-21 June 2014
| |
| ## Plan on a joint DICOM 26/IHE AP F2F
| |
| ## All are encouraged to attend (see brochure)
| |
| # New business
| |
| ## Send out call for new proposals
| |
| ## Need to update the IHE Domain page (Trial Implementation RePub Request; Call for Proposals; Proposal Deadline; # of white papers)
| |
| # Next IHE AP Meetings
| |
| ## Next conference call November 12 (9am Central US)??
| |
| ## F2F meeting planned for Paris around June 18-21, 2014
| |
| ## Proposed F2F to take place during 12th European Congress on Digital Pathology meeting
| |